Cargando…

Biological Recognition-Based Electrochemical Aptasensor for Point-of-Care Detection of cTnI

As a “gold standard biomarker”, cardiac troponin I (cTnI) is widely used to diagnose acute myocardial infarction (AMI). For an early clinical diagnosis of AMI, it is necessary to develop a facile, fast and on-site device for cTnI detection. According to this demand, a point-of-care electrochemical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jianfeng, Feng, Lin, Li, Jie, Zhu, Dan, Wang, Lianhui, Su, Shao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377036/ https://www.ncbi.nlm.nih.gov/pubmed/37504144 http://dx.doi.org/10.3390/bios13070746

Ejemplares similares

An ultrasensitive electrochemical sensing platform for the detection of cTnI based on aptamer recognition and signal amplification assisted by TdT
por: Lang, Mingjian, et al.
Publicado: (2020)

Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)
por: Tannenberg, Robert, et al.
Publicado: (2023)

Differential analysis of transient increases of serum cTnI in response to handling in rats
por: Mikaelian, Igor, et al.
Publicado: (2013)

Relationship between cardiac troponin I (cTnI) release during cardiac operations and myocardial cell death
por: Vazquez-Jimenez, JF, et al.
Publicado: (2000)

Severe Fetal Distress and Placental Damage Might Be Associated with High Troponin I (cTnI) Levels in Mothers
por: Turrini, Irene, et al.
Publicado: (2018)

High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
por: Johannsen, Jessika, et al.
Publicado: (2023)

Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
por: Ma, Jinling, et al.
Publicado: (2023)

An Electrochemical Ti(3)C(2)T(x) Aptasensor for Sensitive and Label-Free Detection of Marine Biological Toxins
por: Ullah, Najeeb, et al.
Publicado: (2021)

Theoretical analysis of immunochromatographic assay and consideration of its operating parameters for efficient designing of high-sensitivity cardiac troponin I (hs-cTnI) detection
por: Agarwal, Rahul, et al.
Publicado: (2023)

Epigallocatechin gallate reverses cTnI‐low expression‐induced age‐related heart diastolic dysfunction through histone acetylation modification
por: Pan, Bo, et al.
Publicado: (2017)

Puerarin pre-conditioning on the expression levels of CK-MB, cTnI and inflammatory factors in patients undergoing cardiac valve replacement
por: Zhou, Yuyang, et al.
Publicado: (2019)

Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments
por: Cimiotti, Diana, et al.
Publicado: (2020)

The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury
por: Huang, Chengjiao, et al.
Publicado: (2021)

Prediction of Perioperative Cardiac Events through Preoperative NT-pro-BNP and cTnI after Emergent Non-Cardiac Surgery in Elderly Patients
por: Ma, Jinling, et al.
Publicado: (2015)

Transitioning high sensitivity cardiac troponin I (hs-cTnI) into routine diagnostic use: More than just a sensitivity issue
por: Lee, Graham R, et al.
Publicado: (2016)

Diagnostic Value of Echocardiography Combined with Serum h-FABP and cTnI in Myocardial Infarction and Its Evaluation Value in Left Ventricular Function
por: Miao, Yanling, et al.
Publicado: (2022)

Aptamers and Aptasensors for Highly Specific Recognition and Sensitive Detection of Marine Biotoxins: Recent Advances and Perspectives
por: Zhao, Lianhui, et al.
Publicado: (2018)

Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study
por: Kruzan, Rachel M., et al.
Publicado: (2016)

Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation
por: Wall, Leona, et al.
Publicado: (2018)

Joint Predictive Value of cTnI and NT-proBNP on Mortality in Patients with Coronavirus Disease 2019: A Retrospective Research in Wuhan, China
por: Weng, Haoyu, et al.
Publicado: (2021)

Retracted: Diagnostic Value of Echocardiography Combined with Serum h-FABP and cTnI in Myocardial Infarction and Its Evaluation Value in Left Ventricular Function
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis
por: Gaze, David C, et al.
Publicado: (2014)

Electrochemical Carbamazepine Aptasensor for Therapeutic Drug Monitoring at the Point of Care
por: Chung, Saeromi, et al.
Publicado: (2022)

Recent Advances in Electrochemical Aptasensors for Detection of Biomarkers
por: Majdinasab, Marjan, et al.
Publicado: (2022)

A simple electrochemical aptasensor for saxitoxin detection
por: Zheng, Weixian, et al.
Publicado: (2022)

Effects of dexmedetomidine on H-FABP, CK-MB, cTnI levels, neurological function and near-term prognosis in patients undergoing heart valve replacement
por: Wang, Zhi, et al.
Publicado: (2017)

Correlations of Changes in Brain Natriuretic Peptide (BNP) and Cardiac Troponin I (cTnI) with Levels of C-Reactive Protein (CRP) and TNF-α in Pediatric Patients with Sepsis
por: Zhang, Yue, et al.
Publicado: (2019)

Fabrication of a Novel and Ultrasensitive Label-Free Electrochemical Aptasensor Based on Gold Nanostructure for Detection of Homocysteine
por: Zaimbashi, Reza, et al.
Publicado: (2023)

The TDs/aptamer cTnI biosensors based on HCR and Au/Ti(3)C(2)-MXene amplification for screening serious patient in COVID-19 pandemic
por: Mi, Xiaona, et al.
Publicado: (2021)

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure
por: Gürgöze, Muhammed T., et al.
Publicado: (2022)

Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors
por: Omage, Joel Imoukhuede, et al.
Publicado: (2022)

Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
por: Cao, Jiatian, et al.
Publicado: (2020)

Determination of Sarcocystis lamacanis microcysts in the cardiac muscle of alpacas (Vicugna pacos) and their correlation with troponin cTnI. A study performed in the high Andean region of southern Peru
por: Fernandez-F, Fernando, et al.
Publicado: (2022)

Aptasensors for Point-of-Care Detection of Small Molecules
por: Prante, Marc, et al.
Publicado: (2020)

Recent Advances in Conventional Methods and Electrochemical Aptasensors for Mycotoxin Detection
por: Ong, Jing Yi, et al.
Publicado: (2021)

Detection of Low Density Lipoprotein—Comparison of Electrochemical Immuno- and Aptasensor
por: Rudewicz-Kowalczyk, Daria, et al.
Publicado: (2021)

Nanomaterial-Based Label-Free Electrochemical Aptasensors for the Detection of Thrombin
por: Yousef, Hibba, et al.
Publicado: (2022)

Dendrimer—Gold Nanocomposite-Based Electrochemical Aptasensor for the Detection of Dopamine
por: Sipuka, Dimpo S., et al.
Publicado: (2023)

Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody**
por: Martínez-Sáez, Nuria, et al.
Publicado: (2015)

Next-Generation Intelligent MXene-Based Electrochemical Aptasensors for Point-of-Care Cancer Diagnostics
por: Parihar, Arpana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_693n5gmmdgo7coig8hjhr02po8